|Articles|May 1, 2020
- Pharmaceutical Executive-05-01-2020
- Volume 40
- Issue 5
Pharmaceutical Executive, May 2020 Issue (PDF)
Click the title above to open the Pharmaceutical Executive May 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 6 years ago
Pharm Exec's Emerging Pharma Leaders 2020about 6 years ago
AI: Kickstarting the Race Against COVID-19about 6 years ago
Competition for Biotech CFOs is Heating Upabout 6 years ago
Biopharma Sustainability Considered Essentialabout 6 years ago
CFOs Outlook: Forging a Sustainable Futureabout 6 years ago
Drive for COVID-19 Therapies Raises Patent and Pricing Issuesabout 6 years ago
Biotech in the Age of COVID: The Pain and the Gainabout 6 years ago
A New, Less Friendly Normal Looms for European Drugmakersover 6 years ago
How Prepared Were Doctors for the COVID Digital Upswing?over 6 years ago
Pharmaceutical Executive, May 2020 Issue (PDF)Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Senior Source Denies AstraZeneca and Bristol Myers Deal Talks : Report
2
Beyond the Megamerger: How Rumored AstraZeneca–BMS Discussions Signal a New Era of Pharmaceutical Competition
3
CSPC Pharmaceutical & AstraZeneca Form Joint Venture for Biologics Manufacturing in China
4
Inside Pharma's Patent Battleground: The Policy Changes Reshaping Generic and Biosimilar Competition
5